SCHEMBL7854754

SCHEMBL7854754

N=C(N)c1ccc2c(OC(=O)C(F)(F)F)c(C(=O)Nc3cccc(Oc4ccccc4)c3)ccc2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLAU P00749 12/20 0.64
▸ PLG P00747 7/20 0.49
▸ PLAT P00750 6/20 0.49
▸ F2 P00734 6/20 0.49
▸ PRSS1 P07477 5/20 0.49
▸ KLKB1 P03952 3/20 0.49
▸ KLK1 P06870 5/20 0.48
▸ F7 P08709 1/20 0.43
▸ HPSE Q9Y251 1/20 0.43
▸ KLK5 Q9Y337 1/20 0.42
▸ GALK1 P51570 1/20 0.42
▸ CASP6 P55212 1/20 0.42
▸ MCL1 Q07820 1/20 0.42
▸ PLEC Q15149 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ F10 P00742 1/20 0.41
▸ HDAC3 O15379 1/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ HDAC7 Q8WUI4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7853605 0.88 PLAU (0.48) PLAUPLGPLATF2PRSS1
SCHEMBL7853919 0.88 PLAU (0.66) PLAUPLGPLATF2PRSS1
SCHEMBL7344367 0.86 PLAU (0.48) PLAUPLGPLATF2PRSS1
SCHEMBL7856137 0.86 PLAU (0.67) PLAUPLGPLATF2PRSS1
SCHEMBL7855528 0.84 PLAU (0.49) PLAUPLGPLATF2PRSS1
Trifluoroacetic Acid SCHEMBL7854751 0.82 PLAU (0.87) PLAUPLGPLATF2PRSS1
SCHEMBL7359141 0.82 PLAU (0.50) PLAUPLGPLATF2PRSS1
SCHEMBL7337835 0.80 PLAU (1.00) PLAUPLGPLATF2PRSS1
SCHEMBL7854268 0.79 NPC1 (0.46) PLAUPLGF2PRSS1KLKB1
SCHEMBL7852369 0.79 SORT1 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010049374-A1 Urokinase inhibitors STEELE ANDREW W (US) 2001-12-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049374-A1 Urokinase inhibitors SERPINE1, PLAU, SERPINB1 PLAU 2/4885PLG 10/4885PLAT 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback